Skip to main content
. 2010 Oct 26;103(10):1518–1523. doi: 10.1038/sj.bjc.6605961

Figure 1.

Figure 1

Progression-free and overall survival under pegylated liposomal doxorubicin therapy in patients previously treated with conventional anthracyclines Eastern Cooperative Oncology Group performance status.